Repligen | RGEN - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Agilent USD 25M 0 2026-03
Align Technology USD 6.93M 9.11M 2026-03
Bio Techne USD 2.17M 9K 2025-12
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Bristol-Myers Squibb USD 407M 4M 2026-06
Bruker USD 8.1M 11.9M 2025-12
Charles River Laboratories USD 26.74M 2.97M 2026-03
Danaher USD 107M 44M 2026-06
Dentsply International USD 24M 2M 2026-03
General Electric Aerospace USD 496M 271M 2025-12
Henry Schein USD 39M 0 2026-03
Illumina USD 24M 2M 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pfizer USD 671M 40M 2026-03
Repligen USD 5.58M 83K 2026-03
Revvity USD 24.72M 1.2M 2026-03
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Waters USD 42M 33.38M 2026-03
West Pharmaceutical Services USD 1.9M 1.7M 2026-03